← Leaderboards
Amber Dahlin
Brigham And Women'S Hospital
$5,254,207
Attributed
$5,254,207
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $999.4K · FY2016–24$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,254,207 · 2
By mechanism
R01$4,436,107 · 1
K01$818,100 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Joshua A Boyce$54,050,346
- Nora Amanda Barrett$12,519,597
- Tanya Maria Laidlaw$5,208,119
- Elliot Israel$35,880,602
- Lora Bankova$3,136,705
Others in their field
Top investigators on “Treatment Response”
- James Dennis Neaton · Northwestern University$283,212,546
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$249,783,490
- David Heimbrook · Leidos Biomedical Research, Inc.$226,464,484
- Jeffrey P Krischer · University Of South Florida$179,054,592
- Lawrence Corey · Fred Hutchinson Cancer Center$168,164,123
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
Research focus
Treatment ResponsePharmaceutical PreparationsGenome Wide Association StudyTreatment ProtocolsOrganPersonalized MedicineGenesGeneticInnovationSamplingMolecularNetwork ModelsComplexPathway InteractionsAsthmaDoctor Of PhilosophyAsthmaticAsthmatic PatientBioinformaticsBiologicalInsightResponseAmberBayesian Network
Grant awards (10)
Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC)$863,786
R01 · FY2024 · HL · contact PI
Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC)$891,259
R01 · FY2023 · HL · contact PI
Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC)$894,839
R01 · FY2022 · HL · contact PI
Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC)$892,154
R01 · FY2021 · HL · contact PI
Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC)$894,069
R01 · FY2020 · HL · contact PI
Role of microRNA molecules in therapeutic response to leukotriene modifying agents in asthma$105,300
K01 · FY2020 · HL · contact PI
Role of microRNA molecules in therapeutic response to leukotriene modifying agents in asthma$178,200
K01 · FY2019 · HL · contact PI
Role of microRNA molecules in therapeutic response to leukotriene modifying agents in asthma$178,200
K01 · FY2018 · HL · contact PI
Role of microRNA molecules in therapeutic response to leukotriene modifying agents in asthma$178,200
K01 · FY2017 · HL · contact PI
Role of microRNA molecules in therapeutic response to leukotriene modifying agents in asthma$178,200
K01 · FY2016 · HL · contact PI